Đang chuẩn bị liên kết để tải về tài liệu:
The GOLMePsA study protocol: An investigator-initiated, double-blind, parallelgroup, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomes

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG Tải xuống

Psoriatic arthritis (PsA) is a chronic inflammatory arthritis which impacts significantly on the quality of life and work capacity of affected individuals. Recent evidence has shown that early control of inflammation in PsA leads to improved long-term outcomes. |